Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

0.9862 -0.0938 (-8.69%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen Inc

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Sell Ocugen Stock Before the Other Shoe Finally Drops
The bad news with Covaxin hasn't sunk in yet with OCGN stock investors, so get out while the stock still remains elevated. 
Via InvestorPlace
Exposures COVID-19
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
What's Going On With Ocugen (OCGN) Stock Today?
Ocugen Inc (NASDAQ: OCGN) shares are trading 1.6% higher in the pre-market session on Wednesday amid high social media interest. The company's shares had closed nearly 2%... 
Via Benzinga
What's Next For Ocugen Stock As It Bounces Off Support?
Ocugen Inc. (NASDAQ:OCGN) shares are trading lower Tuesday... 
Via Benzinga
ROSEN, A LEADING LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important August 17 Deadline in Securities Class Action – OCGN
From The Rosen Law Firm, P.A.
Via Business Wire
NASDAQ:OCGN Shareholder Alert: Lawsuit Alleges Securities Laws Violations by Ocugen, Inc.
San Diego, CA -- (SBWIRE) -- 06/29/2021 -- An investor, who purchased NASDAQ:OCGN shares, filed a lawsuit against Ocugen, Inc. over alleged violations of Federal Securities Laws. 
Via SBWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
If Ocugen Stock Is Worth $8, I’ll Eat My Hat
OCGN stock at $8.35 looks ridiculously overvalued given the change in course 
Via InvestorPlace
Exposures COVID-19
OCGN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ocugen, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Ocugen Stock Is A Bust After Covaxin’s Emergency Use Rejection
OCGN stock is of no value to investors now that federal regulators closed the door on its Covid-19 vaccine commercialization efforts. 
Via InvestorPlace
Exposures COVID-19 Product Safety
Is It Too Late to Buy Ocugen Stock?
The company has found a partner to manufacture its COVID-19 vaccine -- but will it be all for naught? 
Via The Motley Fool
Exposures COVID-19
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Get Rid of Ocugen Stock While You Can as the Bad News Piles Up
After OCGN stock rallied due to factors that were not based on fundamentals, investors should sell the shares. 
Via InvestorPlace
Exposures COVID-19
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN)
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Why Ocugen Climbed 8% Higher Today
The company will join a rarefied club starting early next week. 
Via The Motley Fool
INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN)
From Law Offices of Howard G. Smith
Via Business Wire
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
3 Obscenely Overpriced Stocks I Wouldn't Buy Even if the Market Crashes
A lower price won't address these other risks. 
Via The Motley Fool
SHAREHOLDER ALERT: Robbins LLP Announces That Ocugen, Inc. (OCGN) Is Being Sued for Misleading Shareholders
From Robbins LLP
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
ROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – OCGN
From Rosen Law Firm
Via Business Wire
If You Invested $10,000 in Ocugen in December, This Is How Much You Would Have Today
Now the question is: Can your investment grow from here? 
Via The Motley Fool
Exposures COVID-19
OCUGEN ALERT: Bragar Eagel & Squire, P.C. Is Investigating Ocugen, Inc. on Behalf of Ocugen Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors
From Law Offices of Howard G. Smith
Via Business Wire
Notice of Lead Plaintiff Deadline for Shareholders in the Ocugen, Inc. Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.